跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
IRITEC CONCENTRATE FOR SOLUTION FOR INFUSION 40MG/2ML - HSA Drug Approval Details
Approvals
/
HSA
/
IRITEC CONCENTRATE FOR SOLUTION FOR INFUSION 40MG/2ML
Approved
THERAPEUTIC
IRITEC CONCENTRATE FOR SOLUTION FOR INFUSION 40MG/2ML
VIANEX SA-PLANT C (PALINI PRODUCTION SITE) (GREECE)
🇸🇬 Health Sciences Authority
Approval Date
Aug 2, 2016
Approval ID
acb8b16c90a8563c
Company
VIANEX SA-PLANT C (PALINI PRODUCTION SITE) (GREECE)
Type
Therapeutic
Approval Details
Approval Id
acb8b16c90a8563c
Drug Name
IRITEC CONCENTRATE FOR SOLUTION FOR INFUSION 40MG/2ML
Product Name
IRITEC CONCENTRATE FOR SOLUTION FOR INFUSION 40MG/2ML
Approval Number
SIN15058P
Approval Date
2016-08-02
Registrant
TRANET HOLDINGS PTE LTD
Licence Holder
TRANET HOLDINGS PTE LTD
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
INFUSION, SOLUTION CONCENTRATE
Route Of Administration
INTRAVENOUS
Atc Code
L01XX19
Atc Item Name
xl 01 xx 19
Pharma Manufacturer Name
TRANET HOLDINGS PTE. LTD.
Company Detail Path
/organization/tranet-holdings-pte-ltd
Active Ingredients
Irinotecan Hydrochloride Trihydrate equ to Irinotecan34.66mg/vial
40mg/vial
IRINOTECAN HYDROCHLORIDE TRIHYDRATE EQU TO IRINOTECAN 34.66 MG/VIAL
40 MG/VIAL
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Aug 2, 2016
Approval ID
acb8b16c90a8563c
Type
Therapeutic
Back to HSA Approvals
